The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).

Johnson & Johnson (J&J) has announced that its Tremfya (guselkumab) has been recommended by the European Medicines Agency’s ...

When they opened me up they found a lot of disease in there,' says Anastacia. In fact, she had Crohn's disease, an inflammatory bowel condition that causes a range of distressing symptoms.